Literature DB >> 29089706

Was RA Fisher Right?

Ayush Srivastava1, Anurag Srivastava2, Ravindra M Pandey3.   

Abstract

Randomized controlled trials have become the most respected scientific tool to measure the effectiveness of a medical therapy. The design, conduct and analysis of randomized controlled trials were developed by Sir Ronald A. Fisher, a mathematician in Great Britain. Fisher propounded that the process of randomization would equally distribute all the known and even unknown covariates in the two or more comparison groups, so that any difference observed could be ascribed to treatment effect. Today, we observe that in many situations, this prediction of Fisher does not stand true; hence, adaptive randomization schedules have been designed to adjust for major imbalance in important covariates. Present essay unravels some weaknesses inherent in Fisherian concept of randomized controlled trial.

Keywords:  Adaptive trials; RA Fisher; Randomization

Year:  2017        PMID: 29089706      PMCID: PMC5653589          DOI: 10.1007/s12262-017-1679-y

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  2 in total

Review 1.  Adaptive randomization for clinical trials.

Authors:  William F Rosenberger; Oleksandr Sverdlov; Feifang Hu
Journal:  J Biopharm Stat       Date:  2012       Impact factor: 1.051

2.  R. A. Fisher and his advocacy of randomization.

Authors:  Nancy S Hall
Journal:  J Hist Biol       Date:  2007       Impact factor: 1.326

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.